The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading ->